At Corion Biotech S.r.l. we are committed to develop innovative therapeutic solutions for Women's health. Our technology is based on a specific cell population derived from the human term placenta known as Placental Mesenchymal Stromal Cells (hPDMSCs).
By our property technology, we exploit the unique PDMSCs's therapeutic abilities in-vitro to develop our "Cell Therapy without Cells".
CELL THERAPY WITHOUT CELLS: THE INNOVATIVE APPROACH BY CORION BIOTECH
A cell therapy based on PDMSCs-derived biological cocktails instead of a direct administration of living cells to the patient is a totally new approach which maintains the effectiveness of cell therapy avoiding the risk of direct administration of living allogenic cells.
We strongly believe that our approach is the most ethical, safe and effective solution present in the Advanced Therapy Medicinal Products panorama.
By our property technology, we exploit the unique PDMSCs's therapeutic abilities in-vitro to develop our "Cell Therapy without Cells".
CELL THERAPY WITHOUT CELLS: THE INNOVATIVE APPROACH BY CORION BIOTECH
A cell therapy based on PDMSCs-derived biological cocktails instead of a direct administration of living cells to the patient is a totally new approach which maintains the effectiveness of cell therapy avoiding the risk of direct administration of living allogenic cells.
We strongly believe that our approach is the most ethical, safe and effective solution present in the Advanced Therapy Medicinal Products panorama.
About Us
The Team
Contacts
2013 @CorionBiotech.com All rights reserved - Cookie policy